Balance Assessment Scale and Strength Measurement Protocol to Measure Functionality in Adults With Spinal Deformity

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Spinal Deformity
Interventions
DIAGNOSTIC_TEST

Balance Assessment Scale

The newly developed balance, based on the Balance Evaluation Systems Test (BESTest) and Trunk Control Measurement Scale (TCMS), will be administered by two raters (normative and clinical database + interrater reliability)

DIAGNOSTIC_TEST

Trunk strength measurement with EMG

A trunk strength protocol in sitting position, using a hand-held dynamometer is developed. During the trunk strength measurements muscle activity of certain muscles of the trunk will be measured using surface electromyography (EMG)

DIAGNOSTIC_TEST

MRI spine/pelvis

We will be capturing 3D Magnetic Resonance (MR) images of the subject lying supine with extended knees, using a T1 weighted spine-echo (SE) sequence with interslice distance 3 mm in the area of the hip) extended with full spine MRI images (sagittal full spine T1- and T2- weighted images as part of the standard sagittal view of full spine to check for significant stenosis or spinal cord pathology) and additional T1-weighted axial slices at level L4, T12 and T8 with interslice distance 4 mm.The field of view covers the full spine, pelvis and hip smaller trochanter.

DIAGNOSTIC_TEST

EOS stereoradiographic full body exam

Every subject included in the study will undergo a stereoradiographic full body EOS exam completed with Gravity Line (GL) location, recorded by a force plate on the floor

DIAGNOSTIC_TEST

Balance Assessment Scale 2

Repeating the newly developed balance test (test-retest reliability) within 2 weeks after first measurement

DIAGNOSTIC_TEST

Trunk strength measurement with EMG 2

Repeating the trunk strength protocol with EMG within 2 weeks after the first measurement (test-retest reliability)

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER